- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Good
|
- 10-K Annual report
- 10.6 Exhibit 10.6 Compensation Agreement with Michael K. Handley Dated September 14, 2018
- 10.7 Exhibit 10.7 Director Agreement with Terry Brostwin Dated December 6, 2018
- 10.8 Exhibit 10.8 Director Agreement with James Sapirstein Dated December 6, 2018
- 31.1 Exhibits 31.1 and 31.2 Section 302 Certification
- 32.1 Exhibits 32.1 and 32.2 Section 906 Certifications
- Download Excel data file
- View Excel data file
Exhibit 32.1/32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
I, Michael K. Handley, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)the Annual Report on Form 10-K of Marizyme, Inc. for the fiscal year ended December 31, 2018 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Marizyme, Inc.
Date: March 6, 2019
/s/Michael K. Handley
Michael K. Handley
Chief Executive Officer
(Principal Executive Officer)